Stem's shares tumbled sharply in pre-market trading, sliding 31.5% to $1.35 after the company reported third-quarter 2026 results that fell short of analyst expectations and prompted management to significantly lower its full-year outlook.
For Q3, Stem recorded revenue of $36.7 million, a figure that was about 9% below consensus and represented a 4% decline versus the year-ago quarter. In response to weaker near-term demand and other dynamics, management narrowed full-year 2026 revenue guidance to a range of $132 million to $142 million, down from the prior outlook of $140 million to $190 million. The company also trimmed its year-end annual recurring revenue (ARR) target to $50 million–$55 million, compared with the previous guidance of $65 million–$70 million.
Adding to investor unease, Stem disclosed that it has received a non-compliance notice from the NYSE concerning its market capitalization and stockholders' equity. The company's most recent quarterly filing contains going-concern language. During the earnings call, CEO Arun Narayanan said the notice does not trigger immediate delisting and that Stem intends to file a remediation plan with the exchange.
There were, however, operational developments that point to improved unit economics. Stem's non-GAAP gross margin reached a record 58%, and adjusted EBITDA rose to $7.1 million. Management attributed the profitability improvement in part to a deliberate withdrawal from lower-margin battery hardware resale and managed services, shifting emphasis toward its PowerTrack software offering.
As part of that strategic refocus, the company completed a $10 million cash sale of its Athena distributed battery optimization platform to Voltus. The divestiture was presented as a move to streamline Stem's business around higher-margin software activities.
The broader market offered little shelter for the stock. The report noted the S&P 500 was down about 0.5% in pre-market trading, while the Dow Jones Industrial Average and the Nasdaq Composite were each lower by around 0.6%, leaving growth-oriented names under pressure in early trading.
Taken together, the combination of a revenue miss, sharply reduced top-line guidance, a lower ARR target, and the NYSE non-compliance notice created a heavy negative sentiment that eclipsed improvements in margins and adjusted profitability. Those factors pushed the shares to multi-year lows in pre-market action.
The situation presents a mixed picture: the company has made measurable progress on gross margins and adjusted EBITDA through portfolio pruning and a shift toward software, yet the scale-down in revenue expectations and the regulatory overhang raise near-term financing and market access questions.